Seri Surgical Scaffold
DeviceAn FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.
Other names: Seri, Seri Scaffold
NCT Number: NCT02016612
Will the use of an FDA approved highly purified silk scaffold; Seri Surgical Scaffold help shape and hold the breast up on the chest preventing re-stretching and bottoming out of the breast in breast reduction or augmentation-mastopexy patients? The amount of stretch will be measured manually as well as percent of breast tissue measured with the Canfield Vectra 3-D Imaging system reporting the amount of breast tissue above and below the nipple level.
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Bengtson Center for Aesthetics and Plastic Surgery, Grand Rapids, Michigan, United States
Patients having augmentation mastopexy or breast reduction will be informed about Seri Scaffold and allowed to have Seri support included in their surgery or not. If the choose the scaffold will be placed under the skin in the lower pole of the breast as an internal hammock to help take weight off of the breast and potentially help prevent future stretch of the lower pole.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age =>18 years
Exclusion criteria
An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.
Other names: Seri, Seri Scaffold
Time frame: 1 year post op
The Nipple to fold will be measured manually over time to 1 year
Time frame: 1 year post op
The percentage of breast tissue above and below the horizontal plane of the nipple over time
Bengtson Center
Other
Seri Surgical Scaffold (TM) Support of the Lower Pole of the Breasts in Augmentation Mastopexy or Breast Reduction Patients
Acronym: SeriSupport
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06074107
Disease Attributes, Hemic and Lymphatic Diseases
Beijing, China
View Trial DetailsNCT01211938
Carcinoma, Carcinoma, Squamous Cell
Villejuif, France
View Trial DetailsNCT05969002
Acute Lymphoblastic Leukemia, B Cell
Bethesda, Maryland, United States
View Trial DetailsNCT04939142
Blood Protein Disorders, Cardiovascular Diseases
Hefei, Anhui, China
View Trial Details